BACKGROUND: Circulating levels of sex hormone-binding globulin (SHBG) are inversely associated with breast cancer risk in postmenopausal women. Three polymorphisms within the SHBG gene have been reported to affect SHBG levels, but there has been no systematic attempt to identify other such variants. METHODS: We looked for associations between SHBG levels in 1,134 healthy, postmenopausal women and 11 tagging single nucleotide polymorphisms (SNP) in or around the SHBG gene. Associations between SHBG SNPs and breast cancer were tested in up to 6,622 postmenopausal breast cancer cases and 6,784 controls. RESULTS: Ten SNPs within or close to the SHBG gene were significantly associated with SHBG levels as was the (TAAAA)(n) polymorphism. The best-fitting combination of rs6259, rs858521, and rs727428 and body mass index, waist, hip, age, and smoking status accounted for 24% of the variance in SHBG levels (natural logarithm transformed). Haplotype analysis suggested that rs858518, rs727428, or a variant in linkage disequilibrium with them acts to decrease SHBG levels but that this effect is neutralized by rs6259 (D356N). rs1799941 increases SHBG levels, but the previously reported association with (TAAAA)(n) repeat length appears to be a consequence of linkage disequilibrium with these SNPs. One further SHBG SNP was significantly associated with breast cancer (rs6257, per-allele odds ratio, 0.88; 95% confidence interval, 0.82-0.95; P = 0.002). CONCLUSION: At least 3 SNPs showed associations with SHBG levels that were highly significant but relatively small in magnitude. rs6257 is a potential breast cancer susceptibility variant, but relationships between the genetic determinants of SHBG levels and breast cancer are complex.
BACKGROUND: Circulating levels of sex hormone-binding globulin (SHBG) are inversely associated with breast cancer risk in postmenopausal women. Three polymorphisms within the SHBG gene have been reported to affect SHBG levels, but there has been no systematic attempt to identify other such variants. METHODS: We looked for associations between SHBG levels in 1,134 healthy, postmenopausal women and 11 tagging single nucleotide polymorphisms (SNP) in or around the SHBG gene. Associations between SHBG SNPs and breast cancer were tested in up to 6,622 postmenopausal breast cancer cases and 6,784 controls. RESULTS: Ten SNPs within or close to the SHBG gene were significantly associated with SHBG levels as was the (TAAAA)(n) polymorphism. The best-fitting combination of rs6259, rs858521, and rs727428 and body mass index, waist, hip, age, and smoking status accounted for 24% of the variance in SHBG levels (natural logarithm transformed). Haplotype analysis suggested that rs858518, rs727428, or a variant in linkage disequilibrium with them acts to decrease SHBG levels but that this effect is neutralized by rs6259 (D356N). rs1799941 increases SHBG levels, but the previously reported association with (TAAAA)(n) repeat length appears to be a consequence of linkage disequilibrium with these SNPs. One further SHBG SNP was significantly associated with breast cancer (rs6257, per-allele odds ratio, 0.88; 95% confidence interval, 0.82-0.95; P = 0.002). CONCLUSION: At least 3 SNPs showed associations with SHBG levels that were highly significant but relatively small in magnitude. rs6257 is a potential breast cancer susceptibility variant, but relationships between the genetic determinants of SHBG levels and breast cancer are complex.
Authors: Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland Journal: Am J Hum Genet Date: 2001-12-27 Impact factor: 11.025
Authors: P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki Journal: N Engl J Med Date: 2000-07-13 Impact factor: 91.245
Authors: Elizabeth M Azzato; Kristy E Driver; Fabienne Lesueur; Mitul Shah; David Greenberg; Douglas F Easton; Andrew E Teschendorff; Carlos Caldas; Neil E Caporaso; Paul D P Pharoah Journal: Breast Cancer Res Date: 2008-05-28 Impact factor: 6.466
Authors: L Beckmann; A Hüsing; V W Setiawan; P Amiano; F Clavel-Chapelon; S J Chanock; D G Cox; R Diver; L Dossus; H S Feigelson; C Haiman; G Hallmans; R B Hayes; B E Henderson; R N Hoover; D J Hunter; K Khaw; L N Kolonel; P Kraft; E Lund; L Le Marchand; P H M Peeters; E Riboli; D Stram; G Thomas; M J Thun; R Tumino; D Trichopoulos; U Vogel; W C Willett; M Yeager; R Ziegler; S E Hankinson; R Kaaks Journal: J Clin Endocrinol Metab Date: 2010-12-22 Impact factor: 5.958
Authors: Eva Lundin; Isaac Wirgin; Annekatrin Lukanova; Yelena Afanasyeva; Vittorio Krogh; Tomas Axelsson; Kari Hemminki; Tess V Clendenen; Alan A Arslan; Nina Ohlson; Sabina Sieri; Nirmal Roy; Karen L Koenig; Annika Idahl; Franco Berrino; Paolo Toniolo; Göran Hallmans; Asta Försti; Paola Muti; Per Lenner; Roy E Shore; Anne Zeleniuch-Jacquotte Journal: Cancer Epidemiol Date: 2012-05-25 Impact factor: 2.984
Authors: John M McLaughlin; Susan Olivo-Marston; Mara Z Vitolins; Marisa Bittoni; Katherine W Reeves; Cecilia R Degraffinreid; Steven J Schwartz; Steven K Clinton; Electra D Paskett Journal: Cancer Prev Res (Phila) Date: 2011-03-23
Authors: Federico Canzian; David G Cox; V Wendy Setiawan; Daniel O Stram; Regina G Ziegler; Laure Dossus; Lars Beckmann; Hélène Blanché; Aurelio Barricarte; Christine D Berg; Sheila Bingham; Julie Buring; Saundra S Buys; Eugenia E Calle; Stephen J Chanock; Françoise Clavel-Chapelon; John Oliver L DeLancey; W Ryan Diver; Miren Dorronsoro; Christopher A Haiman; Göran Hallmans; Susan E Hankinson; David J Hunter; Anika Hüsing; Claudine Isaacs; Kay-Tee Khaw; Laurence N Kolonel; Peter Kraft; Loïc Le Marchand; Eiliv Lund; Kim Overvad; Salvatore Panico; Petra H M Peeters; Michael Pollak; Michael J Thun; Anne Tjønneland; Dimitrios Trichopoulos; Rosario Tumino; Meredith Yeager; Robert N Hoover; Elio Riboli; Gilles Thomas; Brian E Henderson; Rudolf Kaaks; Heather Spencer Feigelson Journal: Hum Mol Genet Date: 2010-07-15 Impact factor: 6.150
Authors: Paula L Hyland; Neal D Freedman; Nan Hu; Ze-Zhong Tang; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; Asieh Golozar; William Wheeler; Kai Yu; Jeff Yuenger; Laurie Burdett; Stephen J Chanock; Sanford M Dawsey; Margaret A Tucker; Alisa M Goldstein; Christian C Abnet; Philip R Taylor Journal: Carcinogenesis Date: 2013-01-28 Impact factor: 4.944